NCT04825574 2024-11-26Study for Patients Previously Treated in Avapritinib Clinical TrialsBlueprint Medicines CorporationPhase 4 Completed2 enrolled 4 charts
NCT01735955 2024-02-08Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored StudyNovartisPhase 4 Completed57 enrolled 8 charts